Dramatically improved neurological deficits, reduced brain water contents and infarct sizes at 24 h after stroke and attenuated the over-expression of HMGB1, RAGE, TLR4, and NF-κB induced by ischemia. This evidence concerns the gene TLR4 and stroke disorder.